According to this study, over the next five years the Embolization Particle market will register a 14.1% CAGR in terms of revenue, the global market size will reach $ 2526.7 million by 2025, from $ 1490.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Embolization Particle business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Embolization Particle market by type, application, key manufacturers and key regions and countries.

This study considers the Embolization Particle value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Microspheres

Particles (e.g. PVA Particles, Gelfoam Particles)

Drug-eluting Beads (DEBs)

Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Uterine Fibroid Embolization

Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

Liver Tumor Embolization

Trauma Embolization

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Sirtex Medical

Merit Medical

BTG Medical

Boston Scientific Corporation

Cook Medical

INterface BIOmaterials B.V.

Terumo Corporation

Alicon

HENGRUI Medical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Embolization Particle consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Embolization Particle market by identifying its various subsegments.

Focuses on the key global Embolization Particle manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Embolization Particle with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Embolization Particle submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Embolization Particle Consumption 2015-2025

2.1.2 Embolization Particle Consumption CAGR by Region

2.2 Embolization Particle Segment by Type

2.2.1 Microspheres

2.2.2 Particles (e.g. PVA Particles, Gelfoam Particles)

2.2.3 Drug-eluting Beads (DEBs)

2.2.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

2.3 Embolization Particle Consumption by Type

2.3.1 Global Embolization Particle Consumption Market Share by Type (2015-2020)

2.3.2 Global Embolization Particle Revenue and Market Share by Type (2015-2020)

2.3.3 Global Embolization Particle Sale Price by Type (2015-2020)

2.4 Embolization Particle Segment by Application

2.4.1 Uterine Fibroid Embolization

2.4.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

2.4.3 Liver Tumor Embolization

2.4.4 Trauma Embolization

2.4.5 Other

2.5 Embolization Particle Consumption by Application

2.5.1 Global Embolization Particle Consumption Market Share by Type (2015-2020)

2.5.2 Global Embolization Particle Value and Market Share by Type (2015-2020)

2.5.3 Global Embolization Particle Sale Price by Type (2015-2020)

3 Global Embolization Particle by Company

3.1 Global Embolization Particle Sales Market Share by Company

3.1.1 Global Embolization Particle Sales by Company (2018-2020)

3.1.2 Global Embolization Particle Sales Market Share by Company (2018-2020)

3.2 Global Embolization Particle Revenue Market Share by Company

3.2.1 Global Embolization Particle Revenue by Company (2018-2020)

3.2.2 Global Embolization Particle Revenue Market Share by Company (2018-2020)

3.3 Global Embolization Particle Sale Price by Company

3.4 Global Embolization Particle Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Embolization Particle Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Embolization Particle Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Embolization Particle by Regions

4.1 Embolization Particle by Regions

4.2 Americas Embolization Particle Consumption Growth

4.3 APAC Embolization Particle Consumption Growth

4.4 Europe Embolization Particle Consumption Growth

4.5 Middle East & Africa Embolization Particle Consumption Growth

5 Americas

5.1 Americas Embolization Particle Consumption by Countries

5.1.1 Americas Embolization Particle Consumption by Countries (2015-2020)

5.1.2 Americas Embolization Particle Value by Countries (2015-2020)

5.2 Americas Embolization Particle Consumption by Type

5.3 Americas Embolization Particle Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Embolization Particle Consumption by Regions

6.1.1 APAC Embolization Particle Consumption by Regions (2015-2020)

6.1.2 APAC Embolization Particle Value by Regions (2015-2020)

6.2 APAC Embolization Particle Consumption by Type

6.3 APAC Embolization Particle Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Embolization Particle by Countries

7.1.1 Europe Embolization Particle Consumption by Countries (2015-2020)

7.1.2 Europe Embolization Particle Value by Countries (2015-2020)

7.2 Europe Embolization Particle Consumption by Type

7.3 Europe Embolization Particle Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Embolization Particle by Countries

8.1.1 Middle East & Africa Embolization Particle Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Embolization Particle Value by Countries (2015-2020)

8.2 Middle East & Africa Embolization Particle Consumption by Type

8.3 Middle East & Africa Embolization Particle Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Embolization Particle Distributors

10.3 Embolization Particle Customer

11 Global Embolization Particle Market Forecast

11.1 Global Embolization Particle Consumption Forecast (2021-2025)

11.2 Global Embolization Particle Forecast by Regions

11.2.1 Global Embolization Particle Forecast by Regions (2021-2025)

11.2.2 Global Embolization Particle Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Embolization Particle Forecast by Type

11.8 Global Embolization Particle Forecast by Application

12 Key Players Analysis

12.1 Sirtex Medical

12.1.1 Company Information

12.1.2 Embolization Particle Product Offered

12.1.3 Sirtex Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Sirtex Medical Latest Developments

12.2 Merit Medical

12.2.1 Company Information

12.2.2 Embolization Particle Product Offered

12.2.3 Merit Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Merit Medical Latest Developments

12.3 BTG Medical

12.3.1 Company Information

12.3.2 Embolization Particle Product Offered

12.3.3 BTG Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 BTG Medical Latest Developments

12.4 Boston Scientific Corporation

12.4.1 Company Information

12.4.2 Embolization Particle Product Offered

12.4.3 Boston Scientific Corporation Embolization Particle Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Boston Scientific Corporation Latest Developments

12.5 Cook Medical

12.5.1 Company Information

12.5.2 Embolization Particle Product Offered

12.5.3 Cook Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Cook Medical Latest Developments

12.6 INterface BIOmaterials B.V.

12.6.1 Company Information

12.6.2 Embolization Particle Product Offered

12.6.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 INterface BIOmaterials B.V. Latest Developments

12.7 Terumo Corporation

12.7.1 Company Information

12.7.2 Embolization Particle Product Offered

12.7.3 Terumo Corporation Embolization Particle Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Terumo Corporation Latest Developments

12.8 Alicon

12.8.1 Company Information

12.8.2 Embolization Particle Product Offered

12.8.3 Alicon Embolization Particle Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Alicon Latest Developments

12.9 HENGRUI Medical

12.9.1 Company Information

12.9.2 Embolization Particle Product Offered

12.9.3 HENGRUI Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 HENGRUI Medical Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Embolization Particle Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players